Synedica Tirzepatide 40mg Injection Pen Kit

Tirzepatide is a peptide-based molecule that acts on both the glucose-dependent insulinotropic polypeptide (GIP) receptor and glucagon-like peptide-1 (GLP-1) receptor. Its dual-receptor activity has made tirzepatide an important subject of metabolic and weight-management research.

The Synedica Tirzepatide 40mg Injection Pen Kit is listed by Synedica as containing a total of 40mg of tirzepatide in one pen, together with 12 disposable needles and an instruction booklet.

Product specifications

• Brand: Synedica
• Active ingredient: Tirzepatide
• Total product strength: 40mg
• Format: Injection pen
• Quantity: 1 pen
• Included accessories: 12 disposable needles
• Documentation: Instruction booklet
• Research classification: Tirzepatide has been extensively studied in clinical research

Tirzepatide research

Tirzepatide has been investigated in large randomized clinical trials. In the 72-week SURMOUNT-1 phase 3 trial, researchers studied once-weekly tirzepatide at 5mg, 10mg and 15mg in adults with obesity or overweight and a weight-related complication. The study reported substantial reductions in body weight compared with placebo, with gastrointestinal adverse events among the most common reported adverse events.

Important: The clinical-trial doses above should not be presented as instructions for using the Synedica 40mg product. The 40mg figure describes the total product strength listed by Synedica, while clinical studies evaluated specific treatment regimens under medical research conditions.

These are the outbound links I’d use for Rank Math and, more importantly, for genuine supporting evidence.

Anchor text: Synedica Tirzepatide 40mg product information

Synedica Tirzepatide 40mg Injection Pen Kit

Placement: Product specifications or product-information section.

This gives you relevant outbound links, rather than unrelated links added purely to satisfy Rank Math.

FAQs

What is Synedica Tirzepatide 40mg?

It is a Synedica-branded 40mg tirzepatide injection pen kit. Synedica currently lists one pen, 12 disposable needles and an instruction booklet in the kit.

What is tirzepatide?

Tirzepatide is a dual GIP and GLP-1 receptor agonist that has been investigated in clinical research involving type 2 diabetes, obesity and weight management.

What is included in the Synedica 40mg kit?

Synedica currently lists one 40mg pen, 12 disposable needles and an instruction booklet.

Has tirzepatide been studied for weight management?

Yes. The SURMOUNT-1 phase 3 trial studied tirzepatide in adults with obesity or overweight and a weight-related complication and reported significant weight reduction compared with placebo.

What doses were studied in SURMOUNT-1?

The study evaluated 5mg, 10mg and 15mg once-weekly treatment groups following dose escalation. These clinical-trial regimens should not automatically be interpreted as instructions for a particular commercial product.